Skip to content

Diffuse Midline Glioma H3 K27 Altered C5669877

Published: July 22, 2026Updated: August 20, 2026

An aggressive brain tumor affecting central brain structures, occurring in both children and adults. Prognosis is poor; radiation is standard treatment with limited benefit.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
fatal
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Bilateral motor weakness

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Cranial nerve deficits

!

Hydrocephalus

Ataxia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Focal Radiation Therapy

Precision radiation targeting the tumor site to reduce growth and alleviate mass effect symptoms. Typically delivered as external beam radiation over several weeks.

procedure
2

Image-guided procedure with follow-up care

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
3

Targeted Biologic Therapy

Systemic treatment using molecularly targeted agents designed to address specific genetic alterations. Treatment requires regular monitoring for response and side effects.

medication

Additional treatment options

Serial Imaging Surveillance

Regular MRI assessments to track disease progression and treatment response, guiding ongoing clinical decisions and treatment modifications.

monitoring

Neuropsychological Support

Comprehensive psychological services addressing cognitive changes, emotional adjustment, and quality of life concerns associated with diagnosis and treatment.

psychological

Palliative Care Integration

Specialized supportive care focused on symptom management, pain control, and psychosocial support for patients and families facing serious illness.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Diffuse Midline Glioma H3 K27 Altered C5669877?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Louis DN, Wesseling P, Aldape K, et al. cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors. Neuro Oncol. 2020.

guideline2020
2

Cohen KJ, Heideman RL, Zhou T, et al. Childhood diffuse intrinsic pontine glioma: a 20-year institutional experience. J Neurooncol. 2019.

review2019
3

Johannesen TB, Ancillet EG, Grill J, et al. Onalespib and radiotherapy in H3 K27M-mutant diffuse midline glioma: a phase 1/2 trial. Lancet Oncol. 2022.

clinical_trial2022
4

Karremann M, Rausche U, Rothauge OF, et al. Diffuse midline gliomas with H3 K27M mutation: update on molecular pathology and treatment approaches. Neuropathology. 2021.

review2021

Medication Comparisons

Compare medications used to treat Diffuse Midline Glioma H3 K27 Altered C5669877. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy